Company Filing History:
Years Active: 2015
Title: Walter Paulus: Innovator in Non-Invasive Brain Stimulation
Introduction
Walter Paulus is a distinguished inventor based in Göttingen, Germany. He is known for his groundbreaking work in the field of non-invasive brain stimulation, particularly in the treatment of neurological and psychiatric disorders. His innovative approach has the potential to significantly impact the way these conditions are managed.
Latest Patents
Walter Paulus holds a patent for a "Device for non-invasive, electrical deep-brain stimulation." This invention relates to a device and method for transcranial, non-invasive, electrical deep-brain stimulation. It is particularly useful in treating neurological and psychiatric disorders, as well as disturbances of motor and cognitive functions in the human brain. The device features at least one signal generator that produces an electrical alternating-current signal. An electrode arrangement can be placed on the head of a person to be treated, connecting electrically to the signal generator to apply the alternating-current signal. This arrangement allows for the application of at least two alternating-current signals, which cross the targeted region of the brain, stimulating it effectively while minimizing stimulation to adjacent areas.
Career Highlights
Walter Paulus has made significant contributions to the field of neuroscience through his innovative inventions. His work has been recognized for its potential to improve treatment options for patients suffering from various neurological conditions. He is currently associated with Ebs Technologies GmbH, where he continues to develop and refine his inventions.
Collaborations
Walter Paulus collaborates with Udo Warschewske, working together to advance their research and innovations in brain stimulation technologies.
Conclusion
Walter Paulus is a prominent figure in the field of non-invasive brain stimulation, with a patent that showcases his innovative approach to treating neurological disorders. His contributions have the potential to change the landscape of treatment options available to patients.